Fresh Rounds

HAWKHILL THERAPEUTICS Ltd funding

HAWKHILL THERAPEUTICS Ltd, a biotechnology company based in Dundee, Scotland, United Kingdom (founded 2025), filed a Form D with the SEC on June 23, 2026 and reported $193K raised.

Amount raised$193K
Offering size$193K
Filed with the SECJune 23, 2026
First saleApril 7, 2026
IndustryBiotechnology
SecuritiesEquity
LocationDundee, Scotland, United Kingdom
Founded2025
Entity typeLimited Liability Company
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds